Glipizide Tablet, Extended Release
Product Images NDC 71335-2353

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Glipizide (NDC 71335-2353). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Glipizide Str)

Chemical structure of Glipizide, the active ingredient in the product. The diagram shows the molecular arrangement including nitrogen, oxygen, sulfur atoms, and a cyclohexyl group characteristic of Glipizide.*

FDA Label Image

Label (Lbl713352353)

Glipizide Extended-Release Tablets 10 mg, oral dosage form, repackaged by Bryant Ranch Prepack and manufactured by Aurobindo Pharma Limited. The label indicates 30 tablets per container with storage instructions and a child-resistant container warning. The NDC number is 71335-2353-1.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.